• Neurotensin: Designing Better NTR1 Assays

  2026-08-11

  Neurotensin is a versatile Neurotensin receptor 1 activator for connecting GPCR signaling with receptor trafficking and miR-133α modulation. This assay-design guide adds a critical spectral-quality framework, showing how interference controls and analytical preprocessing can strengthen gastrointestinal cell studies.

• (-)-Blebbistatin in Cardiac Opto-Mechanics

  2026-08-11

  (-)-Blebbistatin is a selective non-muscle myosin II inhibitor for separating cytoskeletal mechanics from cardiac electrical behavior. This guide shows how to combine its reversible actomyosin perturbation with panoramic opto-electrical mapping to design more interpretable cardiac and cell-mechanics assays.

• PD0325901: MEK Inhibition in Cancer Research

  2026-08-10

  PD0325901 is a selective MEK inhibitor that reduces phosphorylated ERK and suppresses tumor growth in selected mouse xenograft models. Its research value includes pathway interrogation, cell-cycle analysis, apoptosis induction in cancer cells, and comparison of MEK-dependent phenotypes with emerging TERT-regulation biology.

• Topological Stress and Persistent rDNA Lesions

  2026-08-09

  Urbancokova, Hornofova and colleagues show that persistent ribosomal DNA damage, rather than genotoxic stress in general, is a central trigger for PML-nucleolar associations (PNAs). By combining chemical stressors with locus-specific I-PpoI cleavage and DNA-repair perturbations, the study connects topoisomerase or RNA polymerase I inhibition to rDNA lesion persistence, incomplete homologous recombination, and cellular senescence.

• CD38 CAR Binder Structures and Affinity Tuning

  2026-08-08

  This iScience study resolves how two CD38-targeting CAR binders, RP02 and 028, engage distinct structural regions and influence enzymatic function. Its structure-guided analysis shows that the attenuated 028R103G variant can reduce CAR-T fratricide while preserving antitumor cytotoxicity, offering a framework for balancing affinity, antigen selectivity, and functional safety.

• Oleanolic Acid: Mechanism and Liposome Research

  2026-08-07

  Oleanolic acid is a natural triterpenoid research compound associated with inducible nitric oxide synthase induction and cyclooxygenase-2 modulation. Its documented inclusion in dual-loaded liposomes also makes it relevant to formulation analytics, while current evidence does not establish clinical antiviral efficacy.

• Safe DNA Gel Stain: Elevating DNA and RNA Gel Visualization

  2026-08-07

  Safe DNA Gel Stain redefines nucleic acid detection by enabling high-sensitivity visualization while minimizing DNA damage and operator risk. With flexible workflows for both agarose and acrylamide gels, it empowers safer, more efficient molecular biology research—especially where cloning fidelity and sample integrity are paramount.

• Cyclosporin in Synaptic and Immune Regulation: Beyond T-Cell

  2026-08-06

  Explore Cyclosporin's dual role in immunosuppression and neuronal signaling, integrating new insights from advanced neurobiology. This in-depth review highlights Cyclosporin A’s unique mechanisms and its expanding utility in both immune and neuroscience research.

• Chlorin e6 Photosensitizer: Protocols and Innovations in PDT

  2026-08-06

  Chlorin e6 (Ce6), a second-generation photosensitizer, is redefining both anticancer photodynamic therapy and advanced antibacterial wound care. This article unpacks experimental workflows, protocol parameters, and troubleshooting strategies for maximizing Ce6’s ROS-driven efficacy in diverse biomedical research applications.

• SR-202 (PPAR Antagonist): Refining Precision in Macrophage P

  2026-08-05

  Discover how SR-202, a selective PPAR antagonist, is transforming macrophage polarization research and enabling advanced assay design in immunometabolism. This article offers unique, actionable insights for insulin resistance and anti-obesity drug development.

• CTP Solution (100 mM): Elevating RNA Synthesis for Precision

  2026-08-05

  Explore how CTP Solution (100 mM) enables high-fidelity RNA synthesis for mRNA-LNP cancer therapies. This article reveals advanced biochemical and workflow insights for researchers seeking translational impact.

• WAY-100635: Precision in Serotonin Receptor Antagonist Resea

  2026-08-04

  WAY-100635, a potent and selective 5-HT1A antagonist, delivers unmatched control for dissecting serotonergic mechanisms in pain, affect, and cognition. This guide details optimized workflows and troubleshooting strategies, leveraging the latest translational findings to empower behavioral, molecular, and imaging studies.

• Dual-Action p38α MAPK Inhibitors: Mechanisms of Enhanced Dep

  2026-08-04

  The reference study reveals how certain kinase inhibitors not only block p38α MAP kinase activity but also accelerate its dephosphorylation by phosphatases, uncovering a dual-action mechanism. These findings suggest new strategies for engineering more selective and potent inhibitors, with implications for inflammation and diabetes research.

• Biotin-HPDP in Immune-Oncology: Precision Thiol Labeling for

  2026-08-03

  Explore how Biotin-HPDP enables thiol-specific protein labeling to advance immune checkpoint research, with a focus on PD-L1 degradation and anti-tumor immunity. This article offers new mechanistic insight, application depth, and practical protocol guidance for oncology and immunology labs.

• Vancomycin: Glycopeptide Antibiotic for MRSA Research Excell

  2026-08-03

  Vancomycin remains the benchmark glycopeptide antibiotic for advanced MRSA and C. difficile infection research, offering robust cell wall-targeting action and high-purity reliability. This guide details applied workflows, comparative insights, and troubleshooting strategies for leveraging Vancomycin in resistance assays and microbiome studies.

15257 records 1/1018 page Next 12345 下5页 Last page